Persbericht: Programma bekend van gebruikersevent GiLab Commit 2019
Amsterdam — 30 augustus 2019 — GitLab, het DevOps platform,... Lees verder →
Not intended for US, Canada and UK-based media -- EU approval based on JAVELIN Renal 101 trial results demonstrating significant improvement in progression-free survival with ...
Lees verderNot intended for US, Canada and UK-based media DARMSTADT, Germany, and NEW YORK, Sept. 27, 2019 /PRNewswire/ -- Merck and Pfizer Inc. today announced the presentation of ...
Lees verderNot intended for US, Canada and UK-based media DARMSTADT, Germany and NEW YORK, Feb. 16, 2019 /PRNewswire/ -- -- JAVELIN Renal 101 shows significant improvement in ...
Lees verderDARMSTADT, Germany and NEW YORK, December 21, 2018 /PRNewswire/ -- Not intended for US, Canada and UK-based media Merck and Pfizer Inc. today announced that data from a ...
Lees verderDARMSTADT, Germany and NEW YORK, November 19, 2018 /PRNewswire/ -- Not intended for US, Canada and UK-based media Merck and Pfizer Inc. today announced that the Phase III ...
Lees verderDARMSTADT, Germany and NEW YORK, February 15, 2018 /PRNewswire/ -- Not intended for UK-based media Merck and Pfizer Inc. today announced results from the Phase III JAVELIN ...
Lees verderDARMSTADT, Germany and NEW YORK, December 21, 2017 /PRNewswire/ -- - Second Breakthrough Therapy Designation for avelumab in hard-to-treat cancer - Renal ...
Lees verderDARMSTADT, Germany, and NEW YORK, USA, September 21, 2017 /PRNewswire/ -- Not intended for US, Canadian and UK-based media - First approved immunotherapy for ...
Lees verderDARMSTADT, Germany and NEW YORK, July 21, 2017 /PRNewswire/ -- Not intended for US, Canadian and UK-based media - If approved, ...
Lees verder